Reciprocal induction of tumor necrosis factor‐α and interleukin‐β activity mediates fibronectin synthesis in coronary artery smooth muscle cells
Authors:
- 1 April 1995
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 163 (1) , 19-29
Abstract
We previously demonstrated an immune‐inflammatory response associated with increased expression of interleukin (IL)‐β and fibronectin in graft coronary arteriopathy in piglets following heterotopic heart transplant. Further studies showed that increased endogenously produced IL‐β was upregulating fibronectin production by donor coronary artery (CA) smooth muscle cells (SMC). Since co‐induction of IL‐β and tumor necrosis factor (TNF)‐α has been shown in other systems, we investigated the possible interaction between these cytokines in regulating fibronectin production in CA SMC. First, we documented increased TNF‐α expression in vivo in donor compared to host CA. Next, synthesis of fibronectin was measured in host and donor CA SMC following [35S]‐methionine radiolabeling and gelatin‐sepharose extraction. As previously shown with IL‐β, increased donor CA SMC fibronectin synthesis was reduced to host levels in the presence of TNF‐α antibodies, and exogenous TNF‐α upregulated fibronectin synthesis in host CA SMC to levels in donor cells. In normal CA SMC, TNF‐α‐stimulated fibronectin production was downregulated to or below control levels in the presence of IL‐β antibodies. Likewise, IL‐β‐stimulated fibronectin synthesis was downregulated to control levels when TNF‐α neutralizing antibodies were added. Combining TNF‐α and IL‐β enhanced fibronectin production over that observed with either cytokine alone, but was not additive. Thus, our studies suggest that vascular SMC fibronectin synthesis is regulated by reciprocal induction of IL‐β and TNF‐α activity and provide the first demonstration of a ‘cytokine loop’ modulating matrix production.Keywords
This publication has 27 references indexed in Scilit:
- IL-1? and TNF? act synergistically to stimulate production of myeloid colony-stimulating factors by cultured human bone marrow stromal cells and cloned stromal cell strainsJournal of Cellular Physiology, 1994
- Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets.Journal of Clinical Investigation, 1993
- Tumor necrosis factor alpha-induced alteration of glycosaminoglycans in cultured vascular smooth-muscle cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Interleukin-1 binding and prostaglandin E2 synthesis by amnion cells in culture: regulation by tumor necrosis factor-α, transforming growth factor-β, and interleukin-1 receptor antagonistBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Fibronectin, hyaluronan, and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migrationDevelopmental Biology, 1991
- TUMOR NECROSIS FACTOR, MACROPHAGE COLONY-STIMULATING FACTOR, AND INTERLEUKIN 1 PRODUCTION WITHIN SPONGE MATRIX ALLOGRAFTS1Transplantation, 1990
- Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblastsFEBS Letters, 1988
- Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Journal of Clinical Investigation, 1988
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.Journal of Experimental Medicine, 1986
- Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.Journal of Experimental Medicine, 1986